Total Payments
$2,706
2024 Payments
$837.29
Companies
27
Transactions
168
Medicare Patients
1,563
Medicare Billing
$107,451
Payment Breakdown by Category
Food & Beverage$2,685 (99.2%)
Education$21.69 (0.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,685 | 167 | 99.2% |
| Education | $21.69 | 1 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $718.37 | 52 | $0 (2024) |
| Janssen Biotech, Inc. | $260.14 | 27 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $184.53 | 11 | $0 (2024) |
| QOL Medical, LLC | $146.06 | 8 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $136.76 | 7 | $0 (2024) |
| MERZ NORTH AMERICA, INC. | $132.30 | 1 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $129.73 | 6 | $0 (2023) |
| Braintree Laboratories, Inc. | $119.92 | 6 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $110.06 | 7 | $0 (2024) |
| GENZYME CORPORATION | $95.24 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $837.29 | 45 | ABBVIE INC. ($322.81) |
| 2023 | $1,032 | 72 | Janssen Biotech, Inc. ($226.47) |
| 2022 | $478.58 | 30 | ABBVIE INC. ($153.98) |
| 2021 | $358.83 | 21 | Novo Nordisk Inc ($46.94) |
All Payment Transactions
168 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | MERZ NORTH AMERICA, INC. | — | Food and Beverage | In-kind items and services | $132.30 | General |
| 12/09/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: Immunology | ||||||
| 12/05/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $2.64 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/30/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $26.90 | General |
| Category: LIVER DISEASE | ||||||
| 10/28/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $3.16 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/04/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/30/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/24/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $32.59 | General |
| Category: IMMUNOLOGY | ||||||
| 09/19/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $5.50 | General |
| Category: IMMUNOLOGY | ||||||
| 09/16/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $7.13 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/12/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $9.43 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/09/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $21.70 | General |
| Category: THERAPY FOR CSID | ||||||
| 09/03/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.47 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/23/2024 | ALBIREO PHARMA, INC. | Bylvay (Drug) | Food and Beverage | In-kind items and services | $22.09 | General |
| Category: Gastroenterology | ||||||
| 08/16/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/12/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $21.70 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/12/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: IMMUNOLOGY | ||||||
| 08/05/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $28.22 | General |
| Category: IMMUNOLOGY | ||||||
| 08/02/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: Immunology | ||||||
| 07/22/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 370 | 467 | $112,773 | $32,785 |
| 2022 | 3 | 337 | 374 | $78,812 | $25,414 |
| 2021 | 5 | 397 | 441 | $84,519 | $31,776 |
| 2020 | 12 | 459 | 517 | $52,475 | $17,476 |
Total Patients
1,563
Total Services
1,799
Medicare Billing
$107,451
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 286 | 383 | $93,069 | $28,057 | 30.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 36 | 36 | $11,448 | $2,546 | 22.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 48 | 48 | $8,256 | $2,182 | 26.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 238 | 273 | $56,499 | $19,390 | 34.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 48 | 48 | $14,912 | $3,680 | 24.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 51 | 53 | $7,401 | $2,345 | 31.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 223 | 262 | $53,248 | $20,413 | 38.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 55 | 55 | $17,050 | $5,813 | 34.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 87 | 90 | $12,330 | $4,831 | 39.2% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 20 | 21 | $1,722 | $679.06 | 39.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 12 | 13 | $169.00 | $39.00 | 23.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 171 | 191 | $26,587 | $9,038 | 34.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 64 | 68 | $15,724 | $4,181 | 26.6% |
| 87804 | Detection test for influenza virus | Office | 2020 | 31 | 58 | $1,592 | $948.02 | 59.5% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 14 | 14 | $1,320 | $809.80 | 61.3% |
| 99202 | New patient office or other outpatient visit, typically 20 minutes | Office | 2020 | 13 | 13 | $1,872 | $773.99 | 41.3% |
| 99211 | Established patient office or other outpatient visit, typically 5 minutes | Office | 2020 | 22 | 22 | $924.00 | $395.90 | 42.8% |
| 87880 | Strep test (streptococcus, group a) | Office | 2020 | 24 | 24 | $965.00 | $391.44 | 40.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 17 | 17 | $667.00 | $265.54 | 39.8% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 26 | 30 | $1,049 | $255.94 | 24.4% |
| 71046 | X-ray of chest, 2 views | Office | 2020 | 17 | 18 | $1,169 | $250.05 | 21.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 34 | 36 | $369.00 | $107.76 | 29.2% |
| 81003 | Automated urinalysis test | Office | 2020 | 26 | 26 | $237.00 | $58.00 | 24.5% |
About Abby Carter
Abby Carter is a Family healthcare provider based in Campbellsville, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/11/2019. The National Provider Identifier (NPI) number assigned to this provider is 1508425844.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Abby Carter has received a total of $2,706 in payments from pharmaceutical and medical device companies, with $837.29 received in 2024. These payments were reported across 168 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($2,685).
As a Medicare-enrolled provider, Carter has provided services to 1,563 Medicare beneficiaries, totaling 1,799 services with total Medicare billing of $107,451. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Campbellsville, KY
- Active Since 06/11/2019
- Last Updated 06/11/2019
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1508425844
Products in Payments
- RINVOQ (Biological) $265.33
- STELARA (Biological) $260.14
- LINZESS (Drug) $197.43
- DUPIXENT (Biological) $169.78
- XIFAXAN (Drug) $128.11
- Linzess (Drug) $110.06
- SUCRAID (Drug) $108.11
- HUMIRA (Biological) $100.93
- SKYRIZI (Biological) $94.49
- ENTYVIO (Biological) $86.00
- CIMZIA (Drug) $78.46
- SUTAB (Drug) $76.54
- OCALIVA (Drug) $68.54
- ZENPEP (Drug) $62.05
- IBSRELA (Drug) $59.46
- CREON (Drug) $56.49
- TRULANCE (Drug) $56.42
- ZEPOSIA (Drug) $56.17
- SUFLAVE (Drug) $43.38
- Sucraid (Drug) $37.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Campbellsville
Ms. Claire Hagan, Aprn, APRN
Family — Payments: $3,382
Family $3,382
Perry Babcock, Aprn, APRN
Family — Payments: $1,793
Family $1,793
Brandy Thompson
Family — Payments: $1,503
Family $1,503
Kimberly Bowen, Arnp, ARNP
Family — Payments: $1,225
Family $1,225
Mrs. Dana Garrett, Aprn, APRN
Family — Payments: $926.67
Family $926.67
Mckenzie Blacketer, Msn, Aprn, Fnp, MSN, APRN, FNP
Family — Payments: $885.97
Family $885.97